Literature DB >> 579976

Structural modifications in contraceptive steroids altering their metabolism and toxicity.

H M Bolt.   

Abstract

Norethisterone and, to a lesser extent, d-norgestrel are metabolically activated by rat liver microsomal enzymes to intermediates which are capable of irreversibly binding to proteins. This microsomal activation in vitro depends on presence of NADPH and is inhibited by glutathione. Irreversible binding of metabolites of progesterone, nortestosterone acetate and cyproterone acetate is very low, compared to that of norethisterone metabolites. Phenol as a reference compound shows quantitatively a similar binding behaviour as norethisterone. Norethisterone-4beta,5beta-epoxide, a microsomal metabolite of norethisterone, binds non-enzymatically to albumin, at a rate of 380 pmol/mg albumin per hour (at 37 degrees). The corresponding rate for norgestrel-4beta,5beta-epoxide, 42 pmol/mg albumin per hour, indicates a considerably lower reactivity of norgestrel-epoxide. The non-SH-proteins concanavalin A and bovine gamma-globulin do not react with either norethisterone-epoxide or norgestrel-epoxide. Also, DNA and RNA show no binding reaction. Thus, the requirements for irreversible protein binding of the 19-nortestosterone progestagens norethisterone and norgestrel are similar to those found for oestrogens which, when activated by rat liver microsomes, only bind to proteins with SH-groups, not to DNA or RNA.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 579976     DOI: 10.1007/bf00343271

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  17 in total

1.  Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes.

Authors:  H Kappus; H Remmer
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

2.  Interaction by 2-hydroxyestrogens with enzymes of drug metabolism.

Authors:  H M Bolt; H Kappus
Journal:  J Steroid Biochem       Date:  1976-04       Impact factor: 4.292

3.  Irreversible protein binding of norethisterone (norethindrone) epoxide.

Authors:  H Kappus; H M Bolt
Journal:  Steroids       Date:  1976-01       Impact factor: 2.668

4.  The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity.

Authors:  U Schwartz; J Hammerstein
Journal:  Acta Endocrinol (Copenh)       Date:  1974-05

5.  Influence of hormonal contraceptives on carbohydrate and lipid metabolism in the rat.

Authors:  E Schillinger; E Gerhards
Journal:  Biochem Pharmacol       Date:  1973-08-01       Impact factor: 5.858

6.  Interactions of steroids and serum cholinesterase.

Authors:  C L Redderson
Journal:  Int J Clin Pharmacol       Date:  1973-08

7.  Effects of some contraceptive steroids on serum proteins of women.

Authors:  M Briggs; M Briggs
Journal:  Biochem Pharmacol       Date:  1973-09-15       Impact factor: 5.858

8.  Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase.

Authors:  H M Bolt; H Kappus
Journal:  J Steroid Biochem       Date:  1974-04       Impact factor: 4.292

9.  Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro.

Authors:  H Kappus; H M Bolt; H Remmer
Journal:  Steroids       Date:  1973-08       Impact factor: 2.668

10.  Oxygenated norethindrone derivatives from incubation with beagle liver. Structure, synthesis, and biological activity.

Authors:  C E Cook; M C Dickey; H D Christensen
Journal:  Drug Metab Dispos       Date:  1974 Jan-Feb       Impact factor: 3.922

View more
  2 in total

1.  The significance of covalent binding of catechols to proteins in vivo.

Authors:  H Remmer; M Scheulen; H Kappus; H M Bolt
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

2.  Metabolic activation of acetylenes. Covalent binding of [1,2-14C]octyne to protein, DNA and haem in vitro and the protective effects of certain thiol compounds.

Authors:  I N White; J B Campbell; P B Farmer; E Bailey; N H Nam; D C Thang
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.